Individuals Stopping Weight-Loss Jabs Gain Back Weight Four Times Faster Than Dieters

Illustration of medical syringe and scale
Obesity treatment often requires ongoing approaches.

A recent study suggests that individuals who discontinue popular GLP-1 drugs like semaglutide or tirzepatide may regain lost weight much more quickly than those who stop traditional lifestyle regimens.

Findings released in a leading medical journal points out that while obese people can lose a large proportion of their total mass while on the medication, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.

"Users buying such medications must be cognizant of the risk of quick weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.

This pace of regain suggests a return to starting weight within about one and a half years.

Analyzing Approaches

The analysis, which reviewed dozens of trials involving over 9,000 of participants, compared the results of the injectable medications with other pills.

Researchers point out that individuals who shed pounds through diet and exercise usually have a slower creep back—around 100 grams monthly—after stopping.

The Reason for the Quick Regain

Experts suggest the mechanism of the injections explains the heightened regain.

The injections imitate a natural hormone called GLP-1, which moderates feelings of fullness.

"Long-term administration of the hormone levels several times higher than normal might result in the body to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.

"Discontinuation of this hormone supplement results in hunger is unsuppressed, making binge eating much more probable."

A Lifelong Disease?

The NHS advise the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

Many experts say that, considering the likelihood of relapse, the treatment might need to be long-term.

This perspective is reinforced by drug manufacturers, who note that the results "emphasize the persistent nature of obesity," similar to managing diseases like diabetes.

User Testimonies

Individuals who have stopped the jabs explain a sudden return of appetite.

"It felt as if something flipping and you're instantly starving," said one woman.

This difficulty is worsened if users have not adopted sustainable lifestyle or habit changes during treatment.

Widespread Interest

Figures show that a significant number of people in the UK have used these injections in the past year, with interest remaining high.

  • Adoption is greater among females compared to men.
  • The middle-aged demographic shows the greatest level of interest.
  • Many obtain the medications through private prescriptions rather than public health services.

In conclusion, clinicians caution that while the jabs are powerful tools for weight loss, they are not a magic cure and lasting health benefits hinges on ongoing lifestyle management.

Casey Contreras
Casey Contreras

Elena Voss is a cloud technology strategist with a passion for simplifying complex infrastructure for modern enterprises.